Hadassah

World-Renowned Orthopedists Gather at Hadassah Medical Center to Discuss Future Trends in Orthopedics

Sunday, Apr 15 2012

Nearly 200 orthopedic surgeons--among them some of the world's most prominent physicians--came to Jerusalem in March to attend the International Symposium on "Future Trends in Orthopedics" at the Hadassah University Medical Center.

The symposium was held on the verge of the historic move of Hadassah's Orthopedics Department into the new Sarah Wetsman Davidson Hospital Tower. Prof. Joseph Iannotti, Chair of the Orthopedic and Rheumatologic Institute at the Cleveland Clinic, Prof. Mark C. Gebhardt, Chief of the Department of Orthopedic Surgery and Orthopedic Surgeon-in-Chief at Beth Israel Deaconess Medical Center in Boston, and Prof. Pietro Regazzoni, Chief of the Orthopedic and Trauma Department at the University of Basel, Switzerland, joined experts from Hadassah and other Israeli hospitals as presenters.

Capturing the enthusiasm for the new Orthopedic facilities in the Tower, Prof. Meir Liebergall, Director of Orthopedics at Hadassah, related: "A move like this is a once-in-a-lifetime event. We now will be able to provide the people of Jerusalem with better health care by every criteria by which hospitals are measured."

Prof. Iannotti began the academic discussions by describing the process of developing individualized tools for joint replacement. In the future, he predicted, artificial joints will be personalized, increasing the precision of the surgeons' work and the implants' longevity. Prof. Gebhardt discussed the change in care for children afflicted with osteosarcoma, the most common primary bone tumor. Thanks to modern medicine, he reported, 70-80 percent of these patients will survive, whereas in the past, 80 percent did not. Surgery for the patients, he explained, has evolved from amputation to limb salvage surgery, giving patients an opportunity for a normal life. Prof. Regazzoni discussed the similarities between surgery and aviation, noting the importance of simulators in the training of surgeons. Accurate documentation of surgery, similar to the black box on planes, he noted, could teach us our flaws and how to improve technique and outcome.

The symposium also served as a forum for nine Israeli start-up companies (including four Hadassah-based projects) to showcase their innovations, which focused on: dealing with pre-operative planning programs for trauma and joint replacement; new implants; robotic surgery; biological treatments for improved healing of bone, cartilage, and tendons; a new method to decrease pulmonary embolism; and improved physical therapy techniques for pre and post surgical care.

A presentation highlighting the pioneering history of the orthopedic department at Hadassah Hospital prepared participants for their futuristic tour of the new department facilities in the Sarah Wetsman Davidson Hospital Tower.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More